Shadowbox technology facilitated orders of Myriad Genetics prostate germline diagnostic, increasing pilot location volume by more than 800%  

SAN DIEGO, MAY 17, 2022 /PRNEWSWIRE/ —  Shadowbox, a leading innovator in healthcare automation solutions, is excited to announce the results of a case study with leading genetic testing company, Myriad Genetics, that not only eliminated cumbersome manual work, but also increased medically appropriate prostate germline diagnostic test orders at pilot locations by more than 800%.…

Read More

Healthcare Has Outgrown the EHR

Accelerated by a worldwide pandemic and a tectonic shift toward telehealth and at-home care, the future of healthcare will demand the connection of multiple data sources to provide full visibility to a patient’s medical history. 

Read More

James Budge Joins Shadowbox Board of Directors

“James is a visionary financial strategist, fundraising powerhouse and Silicon Valley veteran,” said Greg Stein, Shadowbox Co-founder and CEO. “We are ecstatic to welcome James to our board of directors where he is certain to elevate our approach to driving growth and value in the marketplace.”

Read More